Production (Stage)
BriaCell Therapeutics Corp.
BCT.TO
TSX
| 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -13.44% | 571.88% | -7.87% | -85.02% | -54.24% |
| Total Receivables | -11.45% | 229.55% | 4,744.74% | -49.50% | 40.65% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -55.11% | -16.25% | 15.33% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -12.85% | 124.94% | -33.93% | -52.90% | -36.21% |
|
|
|||||
| Total Current Assets | -12.85% | 124.94% | -33.93% | -52.90% | -36.21% |
| Net Property, Plant & Equipment | -6.24% | -5.90% | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -1.94% | -1.90% | -1.87% | -1.83% | -1.85% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.00% | 0.00% | -- | -- | -- |
| Total Assets | -10.09% | 77.35% | -5.34% | -49.28% | -34.31% |
|
|
|||||
| Total Accounts Payable | 18.17% | -40.95% | 11.65% | 73.04% | 755.38% |
| Total Accrued Expenses | -69.84% | 159.88% | -13.42% | 57.54% | -65.25% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 4.86% | -33.14% | 10.41% | 72.20% | 274.99% |
|
|
|||||
| Total Current Liabilities | 4.86% | -33.14% | 10.41% | 72.20% | 274.99% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -47.11% | 56.27% | -80.70% | -65.84% | 10.41% |
| Total Liabilities | -8.43% | -21.69% | -31.19% | -39.48% | 27.61% |
|
|
|||||
| Common Stock & APIC | 4.16% | 13.68% | 3.70% | 0.00% | -10.22% |
| Retained Earnings | -6.89% | -6.79% | -1.44% | 2.00% | -15.13% |
| Treasury Stock & Other | 18.43% | 21.60% | 25.62% | 4.74% | 6,070.08% |
| Total Common Equity | -10.88% | 269.69% | 60.06% | 26.11% | -396.65% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -10.88% | 269.69% | 60.06% | 26.11% | -396.65% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -14.08% | -8.96% | -12.92% | -9.62% | -19.16% |
| Total Equity | -13.09% | 238.29% | 56.92% | 25.06% | -430.54% |
|
|
|||||